Citigroup’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $375M | Buy |
2,969,159
+668,888
| +29% | +$88.1M | 0.12% | 146 |
|
|
2026
Q1 | $321M | Buy |
2,300,271
+524,041
| +30% | +$73.4M | 0.14% | 145 |
|
|
2025
Q4 | $218M | Buy |
1,776,230
+332,996
| +23% | +$40.5M | 0.1% | 187 |
|
|
2025
Q3 | $160M | Sell |
1,443,234
-797,412
| -36% | -$90.6M | 0.07% | 272 |
|
|
2025
Q2 | $248M | Buy |
2,240,646
+191,974
| +9% | +$20.4M | 0.12% | 167 |
|
|
2025
Q1 | $230M | Buy |
2,048,672
+354,472
| +21% | +$36.6M | 0.12% | 158 |
|
|
2024
Q4 | $156M | Sell |
1,694,200
-658,688
| -28% | -$59.3M | 0.09% | 194 |
|
|
2024
Q3 | $197M | Sell |
2,352,888
-126,799
| -5% | -$9.68M | 0.11% | 158 |
|
|
2024
Q2 | $170M | Buy |
2,479,687
+1,019,158
| +70% | +$68M | 0.11% | 169 |
|
|
2024
Q1 | $107M | Sell |
1,460,529
-248,910
| -15% | -$19.1M | 0.07% | 260 |
|
|
2023
Q4 | $138M | Sell |
1,709,439
-270,960
| -14% | -$21.1M | 0.1% | 185 |
|
|
2023
Q3 | $148M | Sell |
1,980,399
-90,454
| -4% | -$6.96M | 0.11% | 149 |
|
|
2023
Q2 | $160M | Buy |
2,070,853
+157,496
| +8% | +$12.6M | 0.1% | 146 |
|
|
2023
Q1 | $159M | Buy |
1,913,357
+68,737
| +4% | +$5.69M | 0.11% | 148 |
|
|
2022
Q4 | $158M | Sell |
1,844,620
-84,044
| -4% | -$6.66M | 0.13% | 145 |
|
|
2022
Q3 | $119M | Buy |
1,928,664
+166,557
| +9% | +$10.5M | 0.09% | 177 |
|
|
2022
Q2 | $109M | Sell |
1,762,107
-439,080
| -20% | -$27.2M | 0.08% | 198 |
|
|
2022
Q1 | $131M | Buy |
2,201,187
+42,378
| +2% | +$2.71M | 0.08% | 225 |
|
|
2021
Q4 | $157M | Buy |
2,158,809
+709,059
| +49% | +$48.8M | 0.08% | 215 |
|
|
2021
Q3 | $101M | Sell |
1,449,750
-211,605
| -13% | -$14.9M | 0.06% | 289 |
|
|
2021
Q2 | $114M | Sell |
1,661,355
-178,262
| -10% | -$11.9M | 0.07% | 266 |
|
|
2021
Q1 | $119M | Sell |
1,839,617
-637,921
| -26% | -$41.1M | 0.08% | 235 |
|
|
2020
Q4 | $144M | Buy |
2,477,538
+271,613
| +12% | +$16.4M | 0.09% | 213 |
|
|
2020
Q3 | $139M | Buy |
2,205,925
+450,684
| +26% | +$31.3M | 0.09% | 175 |
|
|
2020
Q2 | $135M | Sell |
1,755,241
-22,521
| -1% | -$1.73M | 0.11% | 161 |
|
|
2020
Q1 | $133M | Sell |
1,777,762
-4,247
| -0.2% | -$293K | 0.12% | 139 |
|
|
2019
Q4 | $116M | Buy |
1,782,009
+518,680
| +41% | +$33.8M | 0.08% | 209 |
|
|
2019
Q3 | $80.1M | Sell |
1,263,329
-197,061
| -13% | -$12.9M | 0.06% | 294 |
|
|
2019
Q2 | $98.7M | Sell |
1,460,390
-402,543
| -22% | -$26.5M | 0.08% | 234 |
|
|
2019
Q1 | $121M | Buy |
1,862,933
+358,356
| +24% | +$23.8M | 0.12% | 154 |
|
|
2018
Q4 | $94.1M | Sell |
1,504,577
-126,158
| -8% | -$8.82M | 0.1% | 200 |
|
|
2018
Q3 | $126M | Sell |
1,630,735
-94,013
| -5% | -$7.1M | 0.11% | 155 |
|
|
2018
Q2 | $122M | Sell |
1,724,748
-269,861
| -14% | -$19.1M | 0.11% | 145 |
|
|
2018
Q1 | $150M | Sell |
1,994,609
-45,255
| -2% | -$3.6M | 0.12% | 127 |
|
|
2017
Q4 | $146M | Buy |
2,039,864
+683,571
| +50% | +$51.9M | 0.12% | 152 |
|
|
2017
Q3 | $110M | Buy |
1,356,293
+443,460
| +49% | +$33.9M | 0.09% | 187 |
|
|
2017
Q2 | $64.6M | Sell |
912,833
-1,371,765
| -60% | -$91.3M | 0.06% | 270 |
|
|
2017
Q1 | $155M | Buy |
2,284,598
+239,489
| +12% | +$16.8M | 0.14% | 91 |
|
|
2016
Q4 | $146M | Buy |
2,045,109
+341,096
| +20% | +$25.4M | 0.13% | 120 |
|
|
2016
Q3 | $135M | Buy |
1,704,013
+525,720
| +45% | +$42.7M | 0.13% | 128 |
|
|
2016
Q2 | $98.3M | Sell |
1,178,293
-350,959
| -23% | -$31.1M | 0.1% | 177 |
|
|
2016
Q1 | $140M | Sell |
1,529,252
-770,105
| -33% | -$69.4M | 0.16% | 100 |
|
|
2015
Q4 | $233M | Buy |
2,299,357
+771,725
| +51% | +$80.3M | 0.23% | 60 |
|
|
2015
Q3 | $150M | Buy |
1,527,632
+197,464
| +15% | +$21.9M | 0.14% | 107 |
|
|
2015
Q2 | $156M | Sell |
1,330,168
-1,215,988
| -48% | -$133M | 0.14% | 112 |
|
|
2015
Q1 | $250M | Buy |
2,546,156
+1,090,173
| +75% | +$111M | 0.24% | 53 |
|
|
2014
Q4 | $137M | Buy |
1,455,983
+532,421
| +58% | +$55.1M | 0.12% | 151 |
|
|
2014
Q3 | $98.3M | Sell |
923,562
-777,916
| -46% | -$76.2M | 0.09% | 200 |
|
|
2014
Q2 | $141M | Sell |
1,701,478
-54,555
| -3% | -$4.25M | 0.14% | 128 |
|
|
2014
Q1 | $124M | Buy |
1,756,033
+248,690
| +16% | +$19.5M | 0.13% | 117 |
|
|
2013
Q4 | $113M | Buy |
1,507,343
+115,564
| +8% | +$8.05M | 0.1% | 170 |
|
|
2013
Q3 | $87.5M | Sell |
1,391,779
-19,271
| -1% | -$1.15M | 0.08% | 223 |
|
|
2013
Q2 | $72.3M | Buy |
+1,411,050
| New | +$73.5M | 0.07% | 215 |
|
Other funds holding GILD
VCM
VPM
Citigroup's GILD Position: Q2 2026 in Review
Citigroup increased its Gilead Sciences (GILD) stake by 29% in Q2 2026, buying an estimated $88.1M and bringing the position to 2,969,159 shares worth $375M. The position accounts for 0.12% of the portfolio, ranked #146.
Citigroup first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. 1,926 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Citigroup held 2,969,159 shares of Gilead Sciences worth $375M as of Q2 2026.
- Citigroup bought 668,888 Gilead Sciences shares in Q2 2026, an estimated $88.1M.
- Gilead Sciences made up 0.12% of Citigroup's portfolio in Q2 2026, its #146 holding.
- Citigroup first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
- 1,926 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.